in

J&J's Covid-19 vaccine prevents severe disease in preclinical tests (www.pharmaceutical-technology.com)

J&J has reported that the Covid-19 vaccine candidate, developed by the company’s subsidiary Janssen, prevented severe disease in preclinical studies.

This post was created with our nice and easy submission form. Create your post!

What do you think?

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0

Charlotte: Explore the Queen City with Google Arts & Culture (blog.google)

WHO updates guidance on corticosteroids in Covid-19 patients (www.pharmaceutical-technology.com)